CEMI News and Press, Chembio Diagnostics Inc. From 03/12/20

HAUPPAGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the appointment of Richard Eberly as its President and Chief Executive Officer effective March 16, 2020. M...

Chembio Diagnostics (NASDAQ: CEMI ): Q4 GAAP EPS of -$0.23 beats by $0.01 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter and year ended December 31, 2019. Recent Accomplishments & Highl...

Predictive Oncology (NASDAQ: POAI ) +50%  on launching a new AI platform for vaccine and drug development targeting coronaviruses and acute respiratory syndromes. More news on: Predictive Oncology Inc., Chembio Diagnostics, Inc., Alpha Pro Tech, Ltd., Stocks on the move, , Read...

Coronavirus Concerns Have Triggered Momentum In These Penny Stocks Last night U.S. President Trump discussed next steps for the coronavirus. This included a travel ban as well as another reminder to keep your hands clean (among other things). As a result, the market has dropped even lower on T...

HAUPPAUGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that it has entered into a worldwide strategic partnership with LumiraDx Limited to develop...

MEDFORD, N.Y., March 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it successfully completed the technical feasibility phase for a potential companion/compatible diagnos...

Thinly traded nano cap Parallax Health Sciences ( OTCPK:PRLX   +13% ) is, yet another, would-be player in the mad dash for a rapid screening test for COVID-19. More news on: Parallax Health Sciences, Inc., Aytu BioScience, Inc., Co-Diagnostics, Inc., Healthcare stocks news, Stocks on ...

The U.S. Centers for Disease Control and Prevention (CDC) said earlier today that coronavirus testing is now available in 78 state and local laboratories across all 50 states. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellnes...

MEDFORD, N.Y., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a $1.5 million purchase order from UNICEF for multiplex Zika tests and Micro Readers following the successfu...